Identification of Three Novel Fusion Oncogenes, <i>SQSTM1/NTRK3</i> , <i>AFAP1L2/RET</i> , and <i>PPFIBP2/RET</i> , in Thyroid Cancers of Young Patients in Fukushima

Abstract

Three novel fusion oncogenes have been identified in young PTC patients in Fukushima, suggesting that rare fusions may be present among the cases negative for known oncogenes in this age group and that such rearrangements can play a significant role in thyroid carcinogenesis.